Biopharmaceutics Assessment: Identifying the Correct Approach for In Vitro Studies
As part of our small molecule insights series we review the growing importance of biopharmaceutics assessment with Dr. Mark McAllister, Chief Scientific Officer of Biowaived (UK). Mark shares his perspectives on how to identify the correct approach, avoid common pitfalls, and leverage in vitro testing to accelerate successful outcomes in drug product design and clinical exposure/efficacy.
Read More
Biopharmaceutics Assessment: Identifying the Correct Approach for In Vitro Studies.